Azitra, Inc. – AMEX:AZTR

Azitra stock price today

$0.14
-0.32
-69.88%
Financial Health
0
1
2
3
4
5
6
7
8
9

Azitra stock price monthly change

-84.80%
month

Azitra stock price quarterly change

-84.80%
quarter

Azitra key metrics

Market Cap
3.08M
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
-2.57
Revenue
N/A
EBITDA
-11.25M
Income
-11.75M
Revenue Q/Q
-100%
Revenue Y/Y
106.52%
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Azitra stock price history

Azitra stock forecast

Azitra financial statements

Azitra, Inc. (AMEX:AZTR): Profit margin
Jun 2023 172K -4.42M -2575.31%
Sep 2023 310.7K -1.94M -625.46%
Dec 2023 90K -2.45M -2726.43%
Mar 2024 0 -2.93M
Azitra, Inc. (AMEX:AZTR): Analyst Estimates
2025 1.5M -9.56M -637.53%
2026 5.48M -11.93M -217.44%
  • Analysts Price target

  • Financials & Ratios estimates

Azitra, Inc. (AMEX:AZTR): Earnings per share (EPS)
2024-03-15 -0.18 -0.35
Azitra, Inc. (AMEX:AZTR): Debt to assets
Jun 2023 9829557 2.59M 26.38%
Sep 2023 7490244 2.15M 28.81%
Dec 2023 5115486 2.20M 43.05%
Mar 2024 6067993 1.74M 28.74%
Azitra, Inc. (AMEX:AZTR): Cash Flow
Jun 2023 -1.82M -79.30K 6.35M
Sep 2023 -1.74M -96.13K -46.45K
Dec 2023 -2.58M -59.98K 39.06K
Mar 2024 -3.02M -81.07K 4.30M

Azitra alternative data

Azitra, Inc. (AMEX:AZTR): Employee count
Jun 2024 10
Jul 2024 10

Azitra other data

  • What's the price of Azitra stock today?

    One share of Azitra stock can currently be purchased for approximately $0.14.

  • When is Azitra's next earnings date?

    Unfortunately, Azitra's (AZTR) next earnings date is currently unknown.

  • Does Azitra pay dividends?

    No, Azitra does not pay dividends.

  • How much money does Azitra make?

    Azitra has a market capitalization of 3.08M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 141.55% to 686K US dollars. Azitra made a loss 11.28M US dollars in net income (profit) last year or -$0.35 on an earnings per share basis.

  • What is Azitra's stock symbol?

    Azitra, Inc. is traded on the AMEX under the ticker symbol "AZTR".

  • What is Azitra's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Azitra?

    Shares of Azitra can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Azitra have?

    As Jul 2024, Azitra employs 10 workers.

  • When Azitra went public?

    Azitra, Inc. is publicly traded company for more then 2 years since IPO on 20 Jun 2023.

  • What is Azitra's official website?

    The official website for Azitra is azitrainc.com.

  • Where are Azitra's headquarters?

    Azitra is headquartered at 21 Business Park Drive, Branford, CT.

  • How can i contact Azitra?

    Azitra's mailing address is 21 Business Park Drive, Branford, CT and company can be reached via phone at +20 3 6466446.

Azitra company profile:

Azitra, Inc.

azitrainc.com
Exchange:

AMEX

Full time employees:

10

Industry:

Biotechnology

Sector:

Healthcare

Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.

21 Business Park Drive
Branford, CT 06405

CIK: 0001701478
ISIN: US05479L1044
CUSIP: 05479L104